- RON2.13bn
- RON3.66bn
- RON2.21bn
- 66
- 20
- 25
- 27
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 86.8 | ||
| PEG Ratio (f) | 1.41 | ||
| EPS Growth (f) | 159.89% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.08 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.96 | ||
| EV to EBITDA | 12.75 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.89% | ||
| Return on Equity | 0.66% | ||
| Operating Margin | 4.25% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | RONm | 967.38 | 1,077.45 | 1,427.22 | 1,795.43 | 2,211.58 | 2,475.5 | 2,773.1 | 22.72% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -5.52 | +286.91 | +91.71 | -70.16 | -86.2 | +400 | +50 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Med Life SA is a Romania-based company engaged in the healthcare industry. Its portfolio of medical services includes clinical and laboratory testing services, medical imaging, reproductive medicine, hospital admission and surgical interventions, among others. Med Life SA offers treatments in the areas of dental, orthopedics and traumatology, gynecology, plastic and reconstructive surgery, oncology and surgical oncology, infertility and assisted reproduction, medical genetics, and medical checkups, spinal, pediatric and genitourinary surgeries, among others. The Company operates over 10 clinics, around five hospitals, an ambulatory facilities, over 15 test laboratories and around five maternity hospitals, among others.
Directors
- Mihail Marcu CHM (48)
- Adrian Lungu CFO
- Dorin Preda FID (42)
- Nicolae Marcu COO (50)
- Radu Petrescu DHR
- Larisa Chiriac EXB
- Mirela Dogaru EXB
- Geanina Durigu EXB
- Vera Firu EXB
- Mariana Ilea-Brates EXB
- Dimitrie Pelinescu-Onciul NED (71)
- Ion Scorei NED (44)
- Marius Gherghina NID (55)
- Ana Mihaescu NID (63)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 6th, 1996
- Public Since
- December 21st, 2016
- No. of Employees
- 6,281
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Bucharest Stock Exchange- Shares in Issue
- 531,481,968
- Address
- Calea Grivitei, nr. 365, sector 1, BUCURESTI, 012244
- Web
- https://www.medlife.ro/
- Phone
- +40 212094030
- Contact
- Alina-Oana Irinoiu
- Auditors
- Ernst & Young Assurance Services SRL
Upcoming Events for M
Q1 2024 Med Life SA Earnings Release
Q2 2024 Med Life SA Earnings Call
Q2 2024 Med Life SA Earnings Release
FAQ
What is the Med Life SA share price?
As of Today at 19:14 UTC, shares in Med Life SA are trading at RON4.00. This share price information is delayed by 15 minutes.
How has the Med Life SA share price performed this year?
Shares in Med Life SA last closed at RON4.00 and the price had moved by -12.57% over the past 365 days. In terms of relative price strength the Med Life SA share price has underperformed the FTSE Global All Cap Index by -17.92% over the past year.
What are the analyst and broker recommendations for Med Life SA?
The overall consensus recommendation for Med Life SA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Med Life SA dividend yield?
Med Life SA does not currently pay a dividend.
Does Med Life SA pay a dividend?
Med Life SA does not currently pay a dividend.
When does Med Life SA next pay dividends?
Med Life SA does not currently pay a dividend.
How do I buy Med Life SA shares?
To buy shares in Med Life SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Med Life SA?
As of the previous close price of RON4.00, shares in Med Life SA had a market capitalisation of RON2.13bn.
Where are Med Life SA shares listed?
Here are the trading details for Med Life SA:
- Country of listing: Romania
- Exchange: BUH
- Ticker Symbol: M
What kind of share is Med Life SA?
Based on an overall assessment of its quality, value and momentum Med Life SA is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Med Life SA share price forecast for 2024?
The analyst consensus target price for shares in Med Life SA is RON5.61. That is 40.25% above the last closing price of RON4.00.
Analysts covering Med Life SA currently have a consensus Earnings Per Share (EPS) forecast of RON0.04 for the next financial year.
What is the trend in the Med Life SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Med Life SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -22.33%.
As of the last closing price of RON4.00, shares in Med Life SA were trading -6.98% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Med Life SA PE Ratio?
The Med Life SA PE ratio based on its reported earnings over the past 12 months is 86.8. The shares last closed at RON4.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Med Life SA?
Med Life SA's management team is headed by:
- Mihail Marcu - CHM
- Adrian Lungu - CFO
- Dorin Preda - FID
- Nicolae Marcu - COO
- Radu Petrescu - DHR
- Larisa Chiriac - EXB
- Mirela Dogaru - EXB
- Geanina Durigu - EXB
- Vera Firu - EXB
- Mariana Ilea-Brates - EXB
- Dimitrie Pelinescu-Onciul - NED
- Ion Scorei - NED
- Marius Gherghina - NID
- Ana Mihaescu - NID